Actelion suitor raises offer

Actelion Pharmaceuticals suitor Johnson & Johnson has sweetened its offer from its earlier bid of around CHF246 (€225) (US$242) per share. The earlier bid was rejected by Switzerland-based Actelion. Actelion…